Various associations of aging and long-term HIV infection with different neurocognitive functions: detailed analysis of a Japanese nationwide multicenter study.


Journal

Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123

Informations de publication

Date de publication:
04 2019
Historique:
received: 29 06 2018
accepted: 14 11 2018
revised: 12 11 2018
pubmed: 13 3 2019
medline: 12 9 2020
entrez: 13 3 2019
Statut: ppublish

Résumé

Detailed information of the effects of age and long-term HIV infection on various neurocognitive function have not been fully evaluated yet. In a prospective Japanese nationwide multicenter study of 17 facilities (J-HAND study), 728 HIV-infected individuals completed 14 neuropsychological (NP) tests; Verbal Fluency (VF; category and letter), Digit Span (DS; forward and backward), Trail Making Test (TMT) A-B, Rey-Osterrieth Complex Figure Test (ROCFT; copy, immediate and delayed recall), Story Memory Test (SMT; immediate and delayed recall), Digit Symbol Subset (DSS), and the Grooved Pegboard (GP; dominant and non-dominant). Multivariate analysis identified older age (≥ 50 years) to be associated with lower scores in all three ROCFT and GP dominant [odds ratio (OR) [95% confidence interval (CI)] 1.801 (1.217-2.664), 2402 (1.366-3.055), 2.691 (1.720-4.211), and 2.302 (1.145-4.628), respectively], whereas longer time since diagnosis was associated with a lower score in ROCFT (delayed recall) (OR 1.224, 95%CI 1.045-1.434). In VF letter, older age and longer time since diagnosis were associated with a better score [OR (95%CI) 0.449 (0.234-0.861) and 0.831 (0.692-0.997)]. In DSS and TMT-A, longer time since diagnosis was associated with a better score [OR (95%CI): 0.808 (0.670-0.973) and 0.795 (0.665-0.949), respectively]. Older patients in later years since diagnosis are at higher risk of visuospatial and motor impairments despite ART, whereas they are less likely to develop verbal impairment, suggesting that verbal function is relatively resistant to aging and long history of HIV infection under ART. These findings suggest that customtailored supports should be established based on the individual background.

Identifiants

pubmed: 30859496
doi: 10.1007/s13365-018-0704-7
pii: 10.1007/s13365-018-0704-7
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-220

Investigateurs

Aki Watanabe (A)
Ai Takahashi-Nakazato (A)
Sota Kimura (S)
Yoko Kiryu (Y)
Akiko Nakano (A)
Misao Takano (M)
Mikiko Ogata (M)
Yuko Tanaka (Y)
Tomoyuki Endo (T)
Yoko Ishida (Y)
Mitsuo Okawa (M)
Satoshi Hashino (S)
Takeshi Kondo (T)
Katsuya Fujimoto (K)
Hiroki Tsukada (H)
Takafumi Tezuka (T)
Miyuki Takeuchi (M)
Yoshimi Kikuchi (Y)
Hiroyuki Gatanaga (H)
Kunihisa Tsukada (K)
Katsuji Teruya (K)
Hirohisa Yazaki (H)
Ikumi Genka (I)
Takahiro Aoki (T)
Daisuke Mizushima (D)
Taiichiro Kobayashi (T)
Yasuaki Yanagawa (Y)
Hidetoshi Igari (H)
Naruhiko Ishiwada (N)
Noriko Takeuchi (N)
Masako Ishikawa (M)
Reiko Nabae (R)
Moe Tashiro (M)
Ryota Ono (R)
Takayuki Sakurai (T)
Yasuo Ota (Y)
Ichiro Koga (I)
Takatoshi Kitazawa (T)
Kazunori Senoh (K)
Mihoko Kanbe (M)
Takahiro Tanaka (T)
Toshio Naito (T)
Shinichi Fukushima (S)
Yoshiyuki Yokomaku (Y)
Mari Ishihara (M)
Ayuko Matsuoka (A)
Yuko Mori (Y)
Hideho Wada (H)
Takashi Sugihara (T)
Hirofumi Fukuda (H)
Aki Yoshitake (A)
Taizo Tasaka (T)
Hidekazu Nakanishi (H)
Yoshiko Matsuhashi (Y)
Toshinori Kondo (T)
Kasumi Ishiguro (K)
Makie Okada (M)
Etsuko Kadota (E)
Kaoru Mikasa (K)
Sayoko Oyama (S)
Sanae Saito (S)
Yuri Funada (Y)
Takahiro Kinashi (T)
Terumi Hisamoto (T)
Taira Yano (T)
Teruhisa Fujii (T)
Seiji Saito (S)
Naoya Yamazaki (N)
Nobuko Kihana (N)
Ryoko Ogawa (R)
Izumi Asai (I)
Asuka Sato (A)
Kiyonori Takada (K)
Jun Yamanouchi (J)
Koichiro Suemori (K)
Hidemoto Nakanishi (H)
Yuichi Murakami (Y)
Hikaru Yamashita (H)
Joh Sato (J)
Asako Usui (A)
Megumi Takiguchi (M)
Tomoko Furunaga (T)
Kaori Kawamoto (K)
Yuki Takeshige (Y)
Toshie Adachi (T)
Masahiro Yamamoto (M)
Mariko Tsuji (M)
Atsuko Sakaki (A)
Kazuyoshi Saito (K)
Machie Soga (M)
Misako Tanaka (M)
Katsunori Suzuki (K)
Mieko Teramoto (M)
Shuzo Matsushita (S)
Toshikazu Miyakawa (T)
Hirotomo Nakata (H)
Yumiko Ezaki (Y)
Akiko Shibuya (A)
Masatoshi Takaki (M)
Saori Ueno (S)
Kie Takemura (K)
Teruhito Hashiguchi (T)
Yoshinao Furukawa (Y)
Kayo Uemura (K)
Heiichiro Hamada (H)
Hiroshi Takashima (H)
Akira Sano (A)
Chihoko Tabata (C)
Satomi Tsuneyoshi (S)
Yayoi Maemura (Y)
Yasuo Takeda (Y)
Keiko Yachi (K)
None Kazuhiro
None Takahama
Mihoko Tanaka (M)
Niimi Ishihara (N)
Masakaze Matsushita (M)
Masako Iida (M)
Shinnosuke Miyazato (S)
Haruka Makiyama (H)
Masao Tateyama (M)
Daisuke Tominaga (D)
Kaoru Ue (K)
Shuta Nakamura (S)
Futoshi Higa (F)
Kyoko Miyagi (K)
Saori Maeda (S)
Ichiko Oshiro (I)
Yumiko Hedona (Y)
Yumi Tabata (Y)

Références

No To Shinkei. 2004 Jul;56(7):567-74
pubmed: 15379283
Neurology. 2004 Oct 26;63(8):1417-22
pubmed: 15505158
Psychiatry Clin Neurosci. 2005 Oct;59(5):517-26
pubmed: 16194252
Psychiatry Clin Neurosci. 2006 Aug;60(4):422-8
pubmed: 16884442
J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82
pubmed: 17356465
Neurology. 2007 Oct 30;69(18):1789-99
pubmed: 17914061
Arch Neurol. 2008 Aug;65(8):1096-101
pubmed: 18695060
Neurology. 2010 Dec 7;75(23):2087-96
pubmed: 21135382
J Neurovirol. 2011 Feb;17(1):3-16
pubmed: 21174240
HIV Med. 2012 Apr;13(4):245-51
pubmed: 22151608
Clin Infect Dis. 2012 Sep;55(6):868-76
pubmed: 22661489
AIDS. 2013 Jan 28;27(3):391-400
pubmed: 23079813
Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):185-94
pubmed: 23314403
Clin Infect Dis. 2014 Apr;58(7):1015-22
pubmed: 24352352
J Clin Exp Neuropsychol. 2014;36(4):356-67
pubmed: 24645772
J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):120-7
pubmed: 24991974
Curr Opin HIV AIDS. 2014 Nov;9(6):517-20
pubmed: 25203640
Clin Infect Dis. 2015 Feb 1;60(3):473-80
pubmed: 25362201
Neurology. 2015 Jan 20;84(3):231-40
pubmed: 25540304
HIV Med. 2015 Apr;16 Suppl 1:97-108
pubmed: 25711328
Curr HIV/AIDS Rep. 2016 Dec;13(6):399-411
pubmed: 27730446
Alcohol Clin Exp Res. 2016 Dec;40(12):2656-2666
pubmed: 27759882
J Neurovirol. 2017 Jun;23(3):492-500
pubmed: 28321696
AIDS. 2017 Jul 17;31(11):1565-1571
pubmed: 28471765
Lancet HIV. 2017 Sep;4(9):e411-e422
pubmed: 28716545
J Neurovirol. 2017 Dec;23(6):864-874
pubmed: 28971376
AIDS. 2018 May 15;32(8):985-997
pubmed: 29424786
J Neurovirol. 2018 Aug;24(4):514-522
pubmed: 29696578
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538

Auteurs

Kensuke Komatsu (K)

AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.

Ei Kinai (E)

AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan. ekinai@acc.ncgm.go.jp.

Maiko Sakamoto (M)

Center for Comprehensive Community Medicine, Saga University, Saga, Japan.

Toshibumi Taniguchi (T)

Division of Infectious Diseases, Chiba University Hospital, Chiba, Japan.

Aya Nakao (A)

Department of Hematology, Ehime University, Toon, Japan.

Tatsuro Sakata (T)

National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan.

Akiko Iizuka (A)

National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan.

Teppei Koyama (T)

Kagoshima University Hospital, Kagoshima, Japan.

Toki Ogata (T)

Kumamoto University Hospital, Kumamoto, Japan.

Akihiro Inui (A)

Faculty of Medicine, Department of General Medicine, Juntendo University, Tokyo, Japan.

Shinichi Oka (S)

AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH